JMIR Public Health Surveill
May 2017
Background: Work on pharmacovigilance systems using texts from PubMed and Twitter typically target at different elements and use different annotation guidelines resulting in a scenario where there is no comparable set of documents from both Twitter and PubMed annotated in the same manner.
Objective: This study aimed to provide a comparable corpus of texts from PubMed and Twitter that can be used to study drug reports from these two sources of information, allowing researchers in the area of pharmacovigilance using natural language processing (NLP) to perform experiments to better understand the similarities and differences between drug reports in Twitter and PubMed.
Methods: We produced a corpus comprising 1000 tweets and 1000 PubMed sentences selected using the same strategy and annotated at entity level by the same experts (pharmacists) using the same set of guidelines.
Self-reported patient data has been shown to be a valuable knowledge source for post-market pharmacovigilance. In this paper we propose using the popular micro-blogging service Twitter to gather evidence about adverse drug reactions (ADRs) after firstly having identified micro-blog messages (also know as "tweets") that report first-hand experience. In order to achieve this goal we explore machine learning with data crowdsourced from laymen annotators.
View Article and Find Full Text PDF